Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
PerkinElmer announced Michel Vounatsos has been elected to its board of directors, effective March 1, 2020.
read more
ImprimisRx has agreed to a product supply agreement with Vision Center Network of America (VCNA).
read more
Abpro announced the formation of a strategic partnership to advance two bispecific antibodies in key Asian markets including Greater China, Japan, and South Korea.
read more
SIGA entered into a collaboration with Turnstone Biologics to provide TPOXX in connection with Turnstone’s proprietary SKV vaccinia oncolytic immunotherapy platform.
read more
ANI has received approval of the Company's ANDA from the FDA for Memantine Hydrochloride Extended-Release Capsules 7 mg, 14 mg, 21 mg and 28 mg.
read more
Wednesday, March 04, 2020
Alopexx Oncology has entered into an exclusive license agreement with Beijing Shenogen Pharma Group to develop and commercialize DI-Leu16-IL2 in China and other parts of Asia.
read more
Wednesday, March 04, 2020
Among the concerns raised due to the impact of the novel coronavirus is whether patients can count on a reliable supply of medicine.
read more
Wednesday, March 04, 2020
Charles River Laboratories announced the appointment of Nancy C. Andrews, M.D., Ph.D., to its Board of Directors, effective February 28, 2020.
read more
Wednesday, March 04, 2020
Samsung Biologics and STCube announced a strategic development and manufacturing service agreement for STT-003 antibody, an anti-cancer drug candidate.
read more
Wednesday, March 04, 2020
Axiom Real-Time Metrics announced its engagement with Emergent BioSolutions.
read more
Wednesday, March 04, 2020
Takeda Pharmaceutical announced the completion of its previously-announced sale of a portfolio of select products to STADA Arzneimittel for a total value of $660 million USD.
read more
The FDA announced a change to the law will impact compounding of certain products beginning on March 23, 2020.
read more
InterCure announced Canndoc has entered into a strategic partnership agreement with Super-Pharm.
read more
Purolite announced Praesto® Jetted A50, an agarose-based Protein A chromatography resin, has been incorporated into the commercial manufacturing process of an FDA-approved monoclonal antibody treatment by a contract manufacturing organization.
read more
MediWound announced the BARDA has expanded its awarded contract with MediWound providing supplemental funding of $5.5 million to support emergency readiness for NexoBrid deployment upon request of use of NexoBrid in mass casualty situation.
read more